Americans will likely have one more COVID-19 vaccine to choose from after the Food and Drug Administration issued an emergency use authorization for Novavax’s COVID-19 vaccine Wednesday.
It was authorized for use in people 18 years and older.
Novavax is the fourth COVID-19 vaccine to receive emergency use authorization in the U.S. by the FDA.
This is a developing story. Check back for updates.